Crown Laboratories and Revance Therapeutics (RVNC) announced that, on January 17, 2025, they amended their previously announced ...

Crown Laboratories and Revance Therapeutics announced that, on January 17, they amended their previously announced amended and restated merger agreement. Under the terms of the se ...

Revance Therapeutics (RVNC) sees 11% premarket jump as Crown Labs raises bid above Teoxane offer, signaling potential bidding ...

Crown Laboratories plans to raise its takeover price for Revance Therapeutics to $3.65 a share, topping a rival $3.60-a-share bid from Swiss medical-aesthetics company Teoxane.

Revance on Tuesday said it signed a revised merger agreement with privately held Crown, which has extended its tender offer for the Nashville, Tenn., biotechnology company to Feb. 4. Crown raised its ...

Crown Laboratories Tuesday increased its offer price to acquire Revance Therapeutics (NASDAQ:RVNC) to $3.65 per share, a $0.55 per share increase. Improved offer unanimously approved by Revance ...

How should you trade Dr Reddy's Labs, Aegis Logistics, Techno Electric, KFin Technologies, Religare Enterprises, and others on Monday? Dec 23 2024 02:49 AM ...

After hours: January 17 at 7:48:53 PM EST Loading Chart for CCI ...

After hours: January 17 at 6:02:28 PM EST Loading Chart for CCK ...